$1.50/Share Special Dividend and $5M Buyback After $100M Apotex Deal Closes
CPIX has more than doubled off its 52-week low of $1.85 on light trading volume (0.3× avg).
Summary
Cumberland Pharmaceuticals declared a $1.50 per share special cash dividend, returning a significant portion of the $100 million proceeds from its recently closed Apotex asset sale. The dividend, with a July 23 record date and July 31 payment, represents roughly 23% of the current $6.51 stock price. The board also authorized a new $5 million open-market share repurchase program, replacing a prior $10 million plan, and several directors plan to establish share purchase plans. This follows the July 1 closing of the Apotex deal and signals management's commitment to returning capital while retaining the ifetroban development pipeline. The dividend alone is a material cash distribution that will likely attract income-focused investors and could support the stock near-term.
At the time of this announcement, CPIX was trading at $6.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $98M. The 52-week trading range was $1.85 to $7.36. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.